Brexpiprazole
6 NDCs across 1 manufacturer|0 Generic,6 Brand
Brexpiprazole is used to treat major depressive disorder and schizophrenia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 10, 2015, and the first generic was approved Aug 11, 2022. FDA's Orange Book lists 12 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $861 million on Brexpiprazole across 598,000 claims for 95,000 beneficiaries.
Brexpiprazole is available as 6 NDCs from 1 manufacturer (0 generic, 6 brand), with NADAC prices from $49.50 to $49.57 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
0G / 6B
Manufacturers
1
competing in market
Price Spread
$49.50 – $49.57
per EA
7d Activity
avg -0.1% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing BREXPIPRAZOLE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
REXULTI 1 MG TABLET | $49.5742 per EA | -0.01% |
REXULTI 2 MG TABLET | $49.5327 per EA | -0.04% |
REXULTI 3 MG TABLET | $49.5303 per EA | -0.07% |
REXULTI 0.25 MG TABLET | $49.5092 per EA | -0.05% |
REXULTI 0.5 MG TABLET | $49.5054 per EA | -0.02% |
REXULTI 4 MG TABLET | $49.5005 per EA | -0.15% |
Frequently Asked Questions
What is Brexpiprazole used to treat?
Brexpiprazole is used to treat major depressive disorder and schizophrenia, per the National Library of Medicine's MED-RT classification.
When did Brexpiprazole become available as a generic?
FDA approved the first generic Brexpiprazole (ANDA) on Aug 11, 2022. The Orange Book currently lists 12 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Brexpiprazole?
In 2024, Medicare Part D spent $861 million on Brexpiprazole across 598,000 claims for 95,000 beneficiaries.
How many Brexpiprazole products are on the market?
The Brexpiprazole drug market contains 6 NDCs from 1 manufacturer — 0 generic and 6 brand products.
What is the price range for Brexpiprazole?
NADAC reference prices for Brexpiprazole range from $49.5005 to $49.5742 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Brexpiprazole?
1 manufacturer lists Brexpiprazole in NADAC. Ranked by number of NDCs, the largest are Otsuka America Pharmaceutical Inc. (6).
How has the price of Brexpiprazole changed recently?
Over the past 7 days, 0 Brexpiprazole NDCs rose and 6 fell, with a market-wide average change of -0.1%.